Modified-release oral dosage forms can offer benefits to both formulation scientists and patients.
Philippe Gorria
Advertisement
Philippe Gorria is senior director of Pharmaceutical Development at Recipharm.
Articles by Philippe Gorria
Advertisement
Latest Updated Articles
Modified-Release Formulations: Improving Efficacy and Patient CompliancePublished: April 1st 2019 | Updated:
Advertisement
Advertisement
